HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Piet van Riel Selected Research
Piet van Riel Research Topics
Disease
13
Rheumatoid Arthritis
09/2022 - 04/2003
4
Cardiovascular Diseases (Cardiovascular Disease)
09/2022 - 05/2012
4
Rheumatic Diseases (Rheumatism)
01/2021 - 12/2003
3
Necrosis
06/2017 - 06/2010
2
Pain (Aches)
01/2018 - 04/2003
2
Inflammation (Inflammations)
05/2012 - 01/2008
1
Hypertension (High Blood Pressure)
01/2021
1
Diabetes Mellitus
01/2021
1
Gout
12/2017
1
Vasculitis (Vasculitides)
08/2016
1
Myositis (Idiopathic Inflammatory Myopathies)
08/2016
1
Spondylarthropathies
08/2016
1
Connective Tissue Diseases (Connective Tissue Disease)
08/2016
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2016
1
Sarcoidosis (Schaumann Disease)
08/2016
1
Weight Loss (Weight Reduction)
07/2014
1
Infections
06/2010
1
Neoplasms (Cancer)
06/2010
1
Fever (Fevers)
01/2008
Drug/Important Bio-Agent (IBA)
4
Antirheumatic Agents (DMARD)
IBA
01/2021 - 06/2010
4
Methotrexate (Mexate)
FDA Link
Generic
06/2017 - 02/2007
3
Lipids
IBA
09/2022 - 07/2014
3
Biological Products
IBA
01/2021 - 06/2010
3
Acute-Phase Proteins (Acute-Phase Protein)
IBA
01/2018 - 04/2003
2
Glucocorticoids
IBA
01/2021 - 06/2017
2
Sulfasalazine (Azulfidine)
FDA Link
Generic
06/2017 - 06/2012
2
Leflunomide (Arava)
FDA Link
Generic
06/2017 - 12/2003
2
Etanercept (Enbrel)
FDA Link
06/2017 - 07/2007
1
Antihypertensive Agents (Antihypertensives)
IBA
01/2021
1
Uric Acid (Urate)
IBA
12/2017
1
Allopurinol (Remid)
FDA Link
Generic
12/2017
1
Abatacept (Orencia)
FDA Link
06/2017
1
baricitinib
IBA
06/2017
1
clazakizumab
IBA
06/2017
1
tofacitinib
IBA
06/2017
1
tocilizumab (atlizumab)
FDA Link
06/2017
1
golimumab
FDA Link
06/2017
1
sirukumab
IBA
06/2017
1
Certolizumab Pegol
FDA Link
06/2017
1
Adalimumab (Humira)
FDA Link
06/2017
1
Rituximab (Mabthera)
FDA Link
06/2017
1
Infliximab (Remicade)
FDA Link
06/2017
1
sarilumab
IBA
06/2017
1
Janus Kinase Inhibitors
IBA
06/2017
1
Tumor Necrosis Factor Inhibitors
IBA
06/2017
1
Janus Kinases
IBA
06/2017
1
Biosimilar Pharmaceuticals
IBA
06/2017
1
beta-cyclodextrin tetradecasulfate (CTDS)
IBA
08/2016
1
HDL Lipoproteins
IBA
05/2012
1
HDL Cholesterol
IBA
05/2012
1
Interferon Regulatory Factors
IBA
01/2011
1
Azathioprine (Imuran)
FDA Link
Generic
06/2010
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
06/2010
1
canakinumab
FDA Link
01/2008
1
Monoclonal Antibodies
IBA
01/2008
1
Cytokines
IBA
01/2008
1
Interleukin-1 Receptors (Interleukin 1 Receptor)
IBA
01/2008
1
amsonic acid (DAS)
IBA
12/2003
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
04/2003
1
Ro 45-2081
IBA
04/2003
1
Proteins (Proteins, Gene)
FDA Link
04/2003
1
Immunoglobulin G (IgG)
IBA
04/2003
Therapy/Procedure
4
Therapeutics
01/2021 - 07/2014
1
Secondary Prevention
01/2021